Parodi, A.; Righetti, G.; Pesce, E.; Salis, A.; Tomati, V.; Pastorino, C.; Tasso, B.; Benvenuti, M.; Damonte, G.; Pedemonte, N.;
et al. Journey on VX-809-Based Hybrid Derivatives towards Drug-like F508del-CFTR Correctors: From Molecular Modeling to Chemical Synthesis and Biological Assays. Pharmaceuticals 2022, 15, 274.
https://doi.org/10.3390/ph15030274
AMA Style
Parodi A, Righetti G, Pesce E, Salis A, Tomati V, Pastorino C, Tasso B, Benvenuti M, Damonte G, Pedemonte N,
et al. Journey on VX-809-Based Hybrid Derivatives towards Drug-like F508del-CFTR Correctors: From Molecular Modeling to Chemical Synthesis and Biological Assays. Pharmaceuticals. 2022; 15(3):274.
https://doi.org/10.3390/ph15030274
Chicago/Turabian Style
Parodi, Alice, Giada Righetti, Emanuela Pesce, Annalisa Salis, Valeria Tomati, Cristina Pastorino, Bruno Tasso, Mirko Benvenuti, Gianluca Damonte, Nicoletta Pedemonte,
and et al. 2022. "Journey on VX-809-Based Hybrid Derivatives towards Drug-like F508del-CFTR Correctors: From Molecular Modeling to Chemical Synthesis and Biological Assays" Pharmaceuticals 15, no. 3: 274.
https://doi.org/10.3390/ph15030274
APA Style
Parodi, A., Righetti, G., Pesce, E., Salis, A., Tomati, V., Pastorino, C., Tasso, B., Benvenuti, M., Damonte, G., Pedemonte, N., Cichero, E., & Millo, E.
(2022). Journey on VX-809-Based Hybrid Derivatives towards Drug-like F508del-CFTR Correctors: From Molecular Modeling to Chemical Synthesis and Biological Assays. Pharmaceuticals, 15(3), 274.
https://doi.org/10.3390/ph15030274